Delivery Order SPE2DB20D9331-SPE2DB24FL1K2

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $10,555.68 for the supply of 60 tablets of Naltrexone 50 mg. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not associated with any set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. valued at $499,999,999, which allows the DLA to issue firm...
The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,202,280 units of the drug Naltrexone 50 mg tablets. The delivery order has a total potential value of $3,046.56 and a completion date of December 26, 2023. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with the Defense Logistics Agency to supply pharmaceuticals and medical products to military treatment...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $1,490.40 contract is for the supply of 4,566,703,686 units of Naltrexone 50 mg tablets. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a range of prescription drugs, over-the-counter medications, biologics, and medical consumables to military healthcare facilities. This delivery order is part...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of 30-count bottles of 50 mg naltrexone tablets, a medication used to treat opioid addiction. The order has a completion date of January 17, 2024 and a potential value of $3,046.56. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,277.84, is for the supply of 4566146432 - NALTREXONE 50 MG TABLET 60S to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' National CMOP Contracting Office to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of 12,120 packages of 100-count 50mg naltrexone hydrochloride tablets. The total ceiling value of the contract is $193,111.76, with a completion date of March 25, 2024. This award was made under an unrestricted solicitation to fulfill an emergency requirement for these...
The Defense Logistics Agency Troop Support Medical awarded a $148,950 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 50mg naltrexone tablets. Under this order, DMS Pharmaceutical will deliver 30-count bottles of the medication to a location in Park Ridge, Illinois by August 31, 2023. The funding agency, DLA Troop Support Medical, procures and provides medical supplies and equipment in support of military treatment facilities and readiness programs within the...
This federal contract award is for the delivery of 60-count bottles of the drug Naltrexone 50 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $4,650.81 and a completion date of November 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a $3,865.30 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 60-count bottles of 50 mg Naltrexone tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,565,441 units of Naltrexone 50 mg tablets, a medication used to treat opioid and alcohol dependence. The fixed-price contract has a ceiling value of $1,023.20 and an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB24FL1K2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,111.36 firm fixed-price delivery order is for the supply of 60-count packages of Naltrexone 50 mg tablets, with a performance period through July 15, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The contract has no set-aside designation. Through this IDC and other prime vendor contracts, DMS Pharmaceutical Group serves as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and specialized medications to support the diverse medical requirements of military personnel and their dependents.

Generated 1/9/25, 9:14 AM